Medical device company that just made its IPO a couple years ago. Exciting to work for a start-up that is developing devices that aim to cure type II diabetes and obesity.
Cons
There is a certain level of uncertainty in regards to the future of the company because the Endobarrier® is not yet commercially sold in the US, but it is for sale in several European countries and Australia. The product is currently undergoing a pivotal trial in the US.